Royalty Pharma plc (RPD)
Munich
52.19
0.00 (0.00%)
Real-time Data
06:00 AM
Day's Range
52.1952.19
52 wk Range
30.1652.19
Financial Statements - RPD - Royalty Pharma plc
Revenue
2.37B▲ 25.0%
Net Income
1.32B▲ 18.4%Net Margin 55.7%
EBITDA
1.61B▲ 40.2%
Free Cash Flow
2.48B▲ 7.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 2.37B | 1.90B | 2.35B | 2.23B | 2.28B | 2.12B |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 1.55B | 1.08B | 1.49B | 922.89M | 1.43B | 1.66B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 38.74M | 181.96M | 322.83M | -583.20M | -76.90M | 170.18M |
| Pre Tax Income | 1.32B | 1.11B | 1.70B | 230.06M | 1.24B | 1.70B |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | 1.32B | 1.11B | 1.70B | 230.06M | 1.24B | 1.70B |
| EPS Basic | 1.79 | 1.926074 | 2.54 | 0.1 | 1.49 | 2.512013 |
| EPS Diluted | 1.78 | 1.446128 | 2.53 | 0.1 | 1.49 | 2.512013 |
| Basic Shares Outstanding | 429.80M | 374.77M | 466.81M | 449.69M | 425.90M | 398.53M |
| Diluted Shares Outstanding | 429.80M | 374.77M | 466.81M | 449.69M | 425.90M | 398.53M |
| Ebit | 1.63B | 1.30B | 1.88B | 418.02M | 1.40B | 1.85B |
| Ebitda | 1.61B | 1.14B | 1.57B | 983.16M | 1.48B | 1.72B |
| Net Income Continuous Operations | 1.32B | 1.11B | 1.70B | 230.06M | 1.24B | 1.70B |
| Minority Interests | -553.24M | -471.83M | -565.25M | -187.23M | -621.47M | -726.91M |
| Preferred Stock Dividends | - | - | -392.72M | - | - | 479.84M |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
